CBS Daytime Programs Reached 117.6 Million Viewers Last Season

CBS Daytime ended the full 52-week 2015-2016 broadcast year at #1 for the 30th consecutive year, one of the longest winning streaks in television history, which began in 1986.

Highlighting the year were largest-ever audiences for The Talk and Let's Make a Deal, according to Nielsen most current ratings released last week for the full 2015-16 television year.

“This winning streak is an incredible source of pride for all of us at CBS,” said Angelica McDaniel, Executive Vice President, Daytime Programs, CBS Entertainment. “It speaks to three decades of great storytelling from the best creative artists in front of and behind the camera, and the amazing support from a very passionate and loyal fan base.”

CBS Daytime’s 52-Week Full Broadcast Year Highlights

* CBS Daytime averaged 4.13 million viewers, its largest audience since the 2006-07 broadcast year.

* The Talk averaged 2.70 million viewers, up +4% over last year and its most watched season in its six-year history.

Let's Make a Deal 1 (3.29m, up +1%) earned a record audience for any season while Let's Make a Deal 2 (3.55m, even with year ago) matched its record audience from last season. Let's Make a Deal 1 (0.9) and Let's Make a Deal 2 (1.0) both matched its best women 25-54 ratings.

The Price is Right 1 averaged 4.97m, up +3% from last year and its most watched season since 2003-04. The Price is Right 2, daytime’s most-watched program, averaged 5.70m, up +2% from a year ago and its most watched season since 2006-07.

* The Young and the Restless remained daytime’s most watched drama (5.20m) and highest rated in women 25-54 (1.8) and women 18-49 (1.2).

* The Bold and the Beautiful ranked second among daytime dramas in viewers (3.96m) and women 25-54 (1.5).

CBS Daytime programs reached 117.6 million viewers (who watched at least six minutes) and 57.4 million women 18+, more than any other network. The Price is Right 2 (70.9m) and The Price is Right 1 (66.5m) led all daytime programs.

No comments:

Post a Comment